化合物 BQU57|T2267|TargetMol

BQU57
1637739-82-2

￥145 1mg 起订

￥197 2mg 起订

￥325 5mg 起订

上海更新日期：2024-09-29

TargetMol中国（陶术生物）

VIP3年

联系人：邵小姐

手机：4008200310 拨打

邮箱：marketing@tsbiochem.com

产品详情:

中文名称：: 化合物 BQU57

英文名称：: BQU57

CAS号：: 1637739-82-2

品牌：: TargetMol

产地：: 美国

保存条件：: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

纯度规格：: 98.72%

产品类别：: 抑制剂

货号：: T2267

Product Introduction

Bioactivity

名称	BQU57
描述	BQU57 shows selective inhibition for Ral relative to Ras or Rho and inhibit xenograft tumor growth.
细胞实验	Growth inhibition on human lung cancer cells by the compounds are measured under anchorage-independent conditions in soft agar. Cells are seeded into 6-well plates (coated with a base layer made of 2.0 mL of 1% low-melting-point agarose) at 15,000 cells per well in 3.0 mL of 0.4% low-melting-point agarose containing various concentration of drug. Two to four weeks (depending on cell line) after incubation, cells are stained with 1.0 mg/mL Nitro Blue Tetrazolium and colonies are counted under a microscope. The IC50 values are defined as the concentration of drug that resulted in 50% reduction in colony number compared to DMSO treated control. After 48 hr, cells are subjected to the soft agar colony formation assay. (Only for Reference)
激酶实验	HDAC Enzyme Assay: The commercially availablae human recombinant enzyme and fluorogenic HDAC assay kits have used to measure percent inhibition and IC50 values of three HDAC isozymes (HDAC2, HDAC4, HDAC6). Briefly, the inhibitor is added sequentially to a black, flat-bottom 96-well microtiter plate, and the reaction mixture is incubated for 30 min at 37°C. The potent HDAC inhibitor trichostatin A (included in the assay kit) is added to the bifunctional HDAC assay developer at a final reaction concentration of 1 μM to stop deacetylation and initiate the release of the fluorophore. The reaction mixture is further incubated at room temperature for 15 min. Fluorescence is measured on a Spectra Max Gemini XPS using an excitation wavelength of 360 nm and a detection wavelength of 460 nm.
体外活性	50 mg/kg,i.p. BQU57在负荷人肺H2122肿瘤的小鼠体内,明显抑制RalA和RalB的活化,并且剂量依赖性抑制肿瘤生长.
体内活性	BQU57抑制H2122和H358细胞系中RalA与RalB活化,从而引起细胞生长抑制。
存储条件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	Ethanol : 16 mg/mL (47.9 mM) DMSO : 40 mg/mL (119.65 mM) H2O : < 1 mg/mL (insoluble or slightly soluble)
关键字	inhibit \| BQU 57 \| Ras \| BQU57 \| Inhibitor \| BQU-57
相关产品	Exo-1 \| BI-2493 \| CASIN \| (S)-(-)-Perillyl alcohol \| RMC-6236 \| Adagrasib \| IMM-01 \| Sotorasib \| Tyrphostin 8 \| MRTX1133 \| Ketoconazole \| Salirasib
相关库	抑制剂库 \| 经典已知活性库 \| 抗癌化合物库 \| 已知活性化合物库 \| 激酶抑制剂库 \| 谷氨酰胺代谢化合物库 \| GPCR靶点分子库 \| 膜蛋白靶向化合物库 \| 疼痛相关化合物库 \| 细胞重编程化合物库

BQU57|TargetMol

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿，致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区，已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库，以及多种类型的生化试剂产品，包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等，此外，我们还建设有CADD（计算机辅助药物设计）研究中心、药理实验室、药化合成平台三大技术中心，全方位满足客户的定制需求。凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持，我们将有效帮助您缩短研发周期，取得更成功的结果。

成立日期	(12年)
注册资本	566.265100万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,工厂,试剂,定制,服务
主营行业	天然产物,生化试剂,分子生物学,分子砌块,生物技术服务